Olympus traded at 1,434.00 this Wednesday March 25th, increasing 26.00 or 1.85 percent since the previous trading session. Looking back, over the last four weeks, Olympus gained 3.76 percent. Over the last 12 months, its price fell by 29.03 percent. Looking ahead, we forecast Olympus to be priced at 1,314.78 by the end of this quarter and at 1,152.00 in one year, according to Trading Economics global macro models projections and analysts expectations.
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.